Seno Medical's Imagio Breast Imaging System Receives Innovative Technology Contract from Vizient

Seno Medical's Imagio Breast Imaging System Gets Innovative Technology Contract from Vizient

Seno Medical Instruments Inc., based in San Antonio, Texas, has recently announced a significant milestone for its Imagio® Breast Imaging System with the awarding of an Innovative Technology contract by Vizient, Inc. This recognition comes at a time when the importance of innovation in healthcare cannot be overstated.

Recognition by Vizient

Vizient, a leading provider-driven healthcare performance improvement company, manages an extensive network which includes a variety of healthcare providers, ranging from academic medical centers to community hospitals. The Innovative Technology contract awarded to Seno Medical signifies that the Imagio® System is regarded highly by hospital experts within Vizient’s customer-led councils. This endorsement points to the system's unique potential to enhance the healthcare industry’s diagnostic capabilities.

The Innovative Technology designation is not just a form of acknowledgment but a testament to the possibilities that the Imagio® Breast Imaging System holds for improving clinical care and patient outcomes. This program evaluates products based on extensive reviews and interactions, focusing on those that can significantly affect clinical care, healthcare worker safety, and the operational efficiency of healthcare organizations.

What Makes Imagio® Unique?

The Imagio® Breast Imaging System represents a revolutionary advancement in breast cancer diagnostics. By integrating a novel combination of artificial intelligence (AI), opto-acoustic technology, and ultrasound imaging, Imagio® helps physicians differentiate between benign and malignant breast lesions more effectively. The application of SenoGram®, an embedded AI tool, aids in characterizing masses that may require further evaluation while providing real-time, high-resolution images.

Tom Umbel, the CEO of Seno Medical, expressed gratitude for the contract, emphasizing that the innovative technologies highlighted by Vizient represent the cutting edge of patient care. Umbel stated, "We are honored to receive this designation from Vizient and look forward to working with its provider customers to offer the Imagio® Breast Imaging System."

The Technology Behind Imagio®

Imagio® operates utilizing a combination of functional, anatomical, and morphological imaging, distinctly characterized by using light and sound waves to create high-contrast images that offer critical insights into the nature of suspicious breast masses. Unlike traditional mammography, the Imagio® system is non-invasive, does not utilize ionizing radiation or contrast agents, and eliminates the discomfort connected with breast compression, thereby enhancing the patient experience.

Importantly, the Imagio® system provides same-day results, which drastically improves workflow efficiency in clinical settings and minimizes patient anxiety associated with waiting for diagnostic outcomes.

Future Prospects and Industry Impact

The Innovative Technology Exchange organized by Vizient provides an exceptional platform for healthcare providers to interact with advanced technologies that can influence the healthcare landscape. Kelly Flaharty, senior director of contract services at Vizient, remarked on the value that Seno Medical brings to the table, stating her excitement about their participation in the Exchange.

Seno Medical is committed to improving the efficiency and accessibility of breast cancer diagnostics through its groundbreaking opto-acoustic imaging technology. With the U.S. FDA approval for the Imagio® system granted in January 2021, and further validation with a supplemental approval in June 2022, the company continues to make strides in reducing complexities in breast cancer diagnostics.

The advancements in technology have not gone unnoticed, as Seno Medical was honored with the 2023 Enabling Technology Leadership award by Frost & Sullivan, emphasizing the innovative drive of the company in the field of medical imaging.

To explore the cutting-edge imaging technology offered by Seno Medical, interested parties can visit their website for more details and future developments in the realm of breast cancer diagnostics.